These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30788878)

  • 21. Utility of Surgery/Radiotherapy in Distant Metastatic Head and Neck Squamous Cell Carcinoma: A Population-Based Approach.
    Patel TD; Marchiano E; Chin OY; Kilic S; Eloy JA; Baredes S; Park RC
    Otolaryngol Head Neck Surg; 2016 May; 154(5):868-74. PubMed ID: 26884368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial parities in outcomes after radiotherapy for head and neck cancer.
    Liu GF; Ranck MC; Solanki AA; Cao H; Kolokythas A; Wenig BL; Chen L; Ard S; Weichselbaum RR; Halpern H; Spiotto MT
    Cancer; 2014 Jan; 120(2):244-52. PubMed ID: 24122486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-life efficacy of volumetric modulated arc therapy in head and neck squamous cell carcinoma.
    Moncharmont C; Vallard A; Guy JB; Prades JM; Rancoule C; Magné N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 May; 134(3):165-169. PubMed ID: 28034705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Squamous cell carcinoma of the head and neck: management after excisional biopsy of a solitary metastatic neck node.
    Mack Y; Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
    Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):619-22. PubMed ID: 8454479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
    Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
    Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
    Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer.
    Sutera P; Clump DA; Kalash R; D'Ambrosio D; Mihai A; Wang H; Petro DP; Burton SA; Heron DE
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):116-122. PubMed ID: 30149056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic radiosurgery for retreatment of gross perineural invasion in recurrent cutaneous squamous cell carcinoma of the head and neck.
    Tang C; Fischbein NJ; Murphy JD; Chu KP; Bavan B; Dieterich S; Hara W; Kaplan MJ; Colevas AD; Le QT
    Am J Clin Oncol; 2013 Jun; 36(3):293-8. PubMed ID: 22547009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local ablative treatments of oligometastases from head and neck carcinomas.
    Florescu C; Thariat J
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):47-63. PubMed ID: 24556572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.
    Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM
    Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
    Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reirradiation with robotic stereotactic body radiotherapy for recurrent nasopharyngeal carcinoma.
    Dizman A; Coskun-Breuneval M; Altinisik-Inan G; Olcay GK; Cetindag MF; Guney Y
    Asian Pac J Cancer Prev; 2014; 15(8):3561-6. PubMed ID: 24870757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
    Baliga S; Kabarriti R; Ohri N; Haynes-Lewis H; Yaparpalvi R; Kalnicki S; Garg MK
    Head Neck; 2017 Mar; 39(3):595-601. PubMed ID: 27997054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.
    Kress MA; Sen N; Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Hwang J; Harter KW
    Head Neck; 2015 Oct; 37(10):1403-9. PubMed ID: 24824359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study.
    Heron DE; Rwigema JC; Gibson MK; Burton SA; Quinn AE; Ferris RL
    Am J Clin Oncol; 2011 Apr; 34(2):165-72. PubMed ID: 20686406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oligometastatic setting in HNSCC: A critical review by the Rete Oncologica Piemonte e Valle d'Aosta multidisciplinary team.
    Denaro N; Succo G; Ostellino O; Airoldi M; Merlano MC; Badellino S; Solinas C; Garrone O; Iorio GC
    Crit Rev Oncol Hematol; 2023 May; 185():103968. PubMed ID: 36965646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
    Amoils M; Lee CS; Sunwoo J; Aasi SZ; Hara W; Kim J; Sirjani D; Colevas AD; Chang AL; Divi V
    Head Neck; 2017 May; 39(5):881-885. PubMed ID: 28252823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Oligometastatic Disease in Squamous Cell Carcinoma of the Head and Neck.
    Vincent AG; Wang W; Shokri T; Ducic Y
    Laryngoscope; 2021 May; 131(5):E1476-E1480. PubMed ID: 33044014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.